Using ELISA, we found the higher basal level of IL6 secretion in glial cultures differentiated from iPSCs of PD patients with PARK2 mutations when compared to those from HDs at 24 h and 72 h time points (4.5-fold and 4.8-fold, respectively). The gene discussed is PRKN; the disease is Parkinson disease.